Compare MMSI & FSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMSI | FSK |
|---|---|---|
| Founded | 1987 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.5B |
| IPO Year | 1990 | N/A |
| Metric | MMSI | FSK |
|---|---|---|
| Price | $83.25 | $15.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 7 |
| Target Price | ★ $105.38 | $17.93 |
| AVG Volume (30 Days) | 618.0K | ★ 2.6M |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 18.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.95 | 0.97 |
| Revenue | $1,477,128,000.00 | ★ $1,578,000,000.00 |
| Revenue This Year | $13.53 | N/A |
| Revenue Next Year | $6.30 | N/A |
| P/E Ratio | $43.09 | ★ $15.92 |
| Revenue Growth | ★ 11.41 | N/A |
| 52 Week Low | $78.12 | $14.05 |
| 52 Week High | $111.45 | $24.10 |
| Indicator | MMSI | FSK |
|---|---|---|
| Relative Strength Index (RSI) | 41.86 | 48.09 |
| Support Level | $83.84 | $15.06 |
| Resistance Level | $88.71 | $16.31 |
| Average True Range (ATR) | 2.04 | 0.32 |
| MACD | -0.45 | -0.02 |
| Stochastic Oscillator | 12.06 | 32.00 |
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.